4.4 Review

Autophagy in the Heart: Too Much of a Good Thing?

Journal

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
Volume 60, Issue 2, Pages 110-117

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/FJC.0b013e31824cc427

Keywords

cardiac myocytes; autophagy; heart failure; Bnip3; heart; programmed cell death; hypoxia; mitochondria

Funding

  1. Canadian Institutes of Health Research (CIHR)
  2. Heart and Stroke Foundation of Canada (HSFC)
  3. CIHR-MHRC Fellowship
  4. IMPACT Strategic Training Program

Ask authors/readers for more resources

Autophagy constitutes a catabolic process involving lysosomal degradation of damaged and redundant cytosolic components into biomolecules, via an elaborate lysosomal pathway. Autophagy is a highly regulated and evolutionary conserved process crucial for normal tissue homeostasis and cell life. Certain members of the Bcl-2 gene family, including the BH3 only protein Bnip3 regulate autophagy during cardiac stress during ischemic or hypoxic injury as means of discarding damaged mitochondria and organelles to avert cell death. Defects in the regulation of autophagy have been associated with a number of human pathologies including cancer, neurodegenerative diseases, and heart failure. Here, we discuss the molecular regulation of autophagy in the heart and cellular demise from too much a good thing.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available